EP3555254A2 - Two-dimensional fractionation of milk fat - Google Patents
Two-dimensional fractionation of milk fatInfo
- Publication number
- EP3555254A2 EP3555254A2 EP17825810.9A EP17825810A EP3555254A2 EP 3555254 A2 EP3555254 A2 EP 3555254A2 EP 17825810 A EP17825810 A EP 17825810A EP 3555254 A2 EP3555254 A2 EP 3555254A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- fat
- fractionation
- fraction
- fractionate
- milk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000005194 fractionation Methods 0.000 title claims abstract description 161
- 235000021243 milk fat Nutrition 0.000 title claims abstract description 69
- 239000003925 fat Substances 0.000 claims abstract description 133
- 239000012530 fluid Substances 0.000 claims abstract description 76
- 239000007858 starting material Substances 0.000 claims abstract description 45
- 239000000203 mixture Substances 0.000 claims abstract description 31
- 238000004519 manufacturing process Methods 0.000 claims abstract description 9
- 235000013336 milk Nutrition 0.000 claims abstract description 8
- 239000008267 milk Substances 0.000 claims abstract description 8
- 210000004080 milk Anatomy 0.000 claims abstract description 8
- 235000019197 fats Nutrition 0.000 claims description 125
- 238000000034 method Methods 0.000 claims description 49
- 230000008569 process Effects 0.000 claims description 40
- 235000013305 food Nutrition 0.000 claims description 24
- 239000000194 fatty acid Substances 0.000 claims description 22
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 15
- 229910052799 carbon Inorganic materials 0.000 claims description 15
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 13
- 235000019219 chocolate Nutrition 0.000 claims description 12
- 235000016709 nutrition Nutrition 0.000 claims description 11
- 150000004667 medium chain fatty acids Chemical class 0.000 claims description 9
- 229930003231 vitamin Natural products 0.000 claims description 9
- 235000013343 vitamin Nutrition 0.000 claims description 9
- 239000011782 vitamin Substances 0.000 claims description 9
- 229940088594 vitamin Drugs 0.000 claims description 9
- 235000012000 cholesterol Nutrition 0.000 claims description 7
- 230000001419 dependent effect Effects 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 5
- 235000021281 monounsaturated fatty acids Nutrition 0.000 claims description 5
- 230000035764 nutrition Effects 0.000 claims description 5
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 5
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 5
- 150000001299 aldehydes Chemical class 0.000 claims description 4
- 230000036541 health Effects 0.000 claims description 4
- 150000002576 ketones Chemical class 0.000 claims description 4
- 150000002596 lactones Chemical class 0.000 claims description 4
- 150000004668 long chain fatty acids Chemical class 0.000 claims description 4
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 4
- 235000010692 trans-unsaturated fatty acids Nutrition 0.000 claims description 4
- 229940050189 cow milk fat Drugs 0.000 claims description 3
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 3
- 235000021391 short chain fatty acids Nutrition 0.000 claims description 3
- 150000004666 short chain fatty acids Chemical class 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 claims description 2
- 235000012041 food component Nutrition 0.000 claims description 2
- 239000005417 food ingredient Substances 0.000 claims description 2
- 235000019871 vegetable fat Nutrition 0.000 claims 2
- 235000008452 baby food Nutrition 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 description 19
- 235000014113 dietary fatty acids Nutrition 0.000 description 18
- 229930195729 fatty acid Natural products 0.000 description 18
- 238000002844 melting Methods 0.000 description 17
- 230000008018 melting Effects 0.000 description 17
- RSPISYXLHRIGJD-UHFFFAOYSA-N OOOO Chemical compound OOOO RSPISYXLHRIGJD-UHFFFAOYSA-N 0.000 description 15
- 239000000796 flavoring agent Substances 0.000 description 15
- 235000019634 flavors Nutrition 0.000 description 15
- 244000299461 Theobroma cacao Species 0.000 description 13
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 11
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 10
- 229910002092 carbon dioxide Inorganic materials 0.000 description 10
- 230000002195 synergetic effect Effects 0.000 description 10
- 239000000126 substance Substances 0.000 description 8
- 150000003626 triacylglycerols Chemical class 0.000 description 8
- 235000020247 cow milk Nutrition 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 6
- 125000002252 acyl group Chemical group 0.000 description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
- 235000014121 butter Nutrition 0.000 description 6
- 239000001569 carbon dioxide Substances 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 235000019155 vitamin A Nutrition 0.000 description 6
- 239000011719 vitamin A Substances 0.000 description 6
- 229940045997 vitamin a Drugs 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 235000021003 saturated fats Nutrition 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 4
- PFRQBZFETXBLTP-UHFFFAOYSA-N Vitamin K2 Natural products C1=CC=C2C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- DKHGMERMDICWDU-GHDNBGIDSA-N menaquinone-4 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 DKHGMERMDICWDU-GHDNBGIDSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 235000019143 vitamin K2 Nutrition 0.000 description 3
- 239000011728 vitamin K2 Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 2
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 230000002902 bimodal effect Effects 0.000 description 2
- 235000001046 cacaotero Nutrition 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 235000013350 formula milk Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 235000020251 goat milk Nutrition 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000009884 interesterification Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940012843 omega-3 fatty acid Drugs 0.000 description 2
- 239000006014 omega-3 oil Substances 0.000 description 2
- 238000000194 supercritical-fluid extraction Methods 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- SJVGFKBLUYAEOK-SFHVURJKSA-N 6-[4-[(3S)-3-(3,5-difluorophenyl)-3,4-dihydropyrazole-2-carbonyl]piperidin-1-yl]pyrimidine-4-carbonitrile Chemical compound FC=1C=C(C=C(C=1)F)[C@@H]1CC=NN1C(=O)C1CCN(CC1)C1=CC(=NC=N1)C#N SJVGFKBLUYAEOK-SFHVURJKSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 1
- GVOIQSXBMLNCLC-UHFFFAOYSA-N OOOS Chemical compound OOOS GVOIQSXBMLNCLC-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 235000020246 buffalo milk Nutrition 0.000 description 1
- -1 butyric acid Chemical class 0.000 description 1
- 235000020248 camel milk Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229960001730 nitrous oxide Drugs 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000020254 sheep milk Nutrition 0.000 description 1
- 238000000526 short-path distillation Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 235000000053 special nutrition Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000005496 tempering Methods 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B7/00—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils
- C11B7/0008—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils by differences of solubilities, e.g. by extraction, by separation from a solution by means of anti-solvents
- C11B7/005—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils by differences of solubilities, e.g. by extraction, by separation from a solution by means of anti-solvents in solvents used at superatmospheric pressures
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B7/00—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils
- C11B7/0075—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils by differences of melting or solidifying points
Definitions
- the invention relates to a process for preparing a fat fractionate from a fat composition comprising milk fat. Further, the invention relates to a fat fraction. Further, the invention relates to a method for preparing a food product, comprising the use a fat fractionate according to the invention.
- Milk fat is complex mixture of triglycerides and other lipid components. Milk fat typically consists for the largest part of triglycerides (e.g. about 98 %).
- the triglycerides generally have a carbon number in the range of 26-54. In particular for milk fat from cow milk, usually, the carbon number distribution is bimodal, i.e.
- milk fat has fatty acids with a relatively high content of relatively small acyl groups (4-6 carbons), a relatively high content of relatively large acyl groups (at least 14 carbons) and a relatively low content of acyl groups of intermediate length (8- 12 carbons),
- milk fat typically contains several minor components, such as cholesterol, fat-soluble vitamins, free fatty acids, monoglycerides, diglycerides and various other organic components, such as lactones, ketones and aldehydes, contributing to the characteristic flavour or aroma of milk fat.
- milk fat contains various highly nutritious components. However, not all ingredients of milk fat are appreciated for their nutritional value. Furthermore, milk fat has characteristic physical properties, e.g. melting range and structural functionalities, e.g. consistency, spreadability and the like. Such properties are desirable for specific applications, but not necessarily so for others. For example, milk fat may be used as a substitute for cocoa-butter in chocolate products or chocolate imitation products (compounds). However, increasing incorporation of milk fat in such products may cause undesirable softening, changes in tempering conditions, gloss or contraction.
- a common process is milk fat fractionation on the basis of melt temperature (dry fractionation, also known as melt crystallisation). This process can be a single-step fractionation or a multi-step fractionation. In each
- fractionation step a liquid phase (marked as '0' for Olein', because this fraction typically is enriched in oleic acid (bound as triglyceride), indicative of long-chain unsaturated fatty acid content) and a solid phase (marked as 'S' for 'stearin' because this fraction typically is enriched in stearic acid (bound as triglyceride), indicative of long-chain fatty acid content).
- a liquid phase marked as '0' for Olein', because this fraction typically is enriched in oleic acid (bound as triglyceride), indicative of long-chain unsaturated fatty acid content
- solid phase marked as 'S' for 'stearin' because this fraction typically is enriched in stearic acid (bound as triglyceride), indicative of long-chain fatty acid content.
- SO is the fluid fraction obtained after the dry fractionating the solid fraction from a first dry fractionation step
- SS would be the solid fraction after that second fractionation step.
- OOO is the fluid fraction of a triple dry fractionation process wherein the liquid phase of a first fractionation (O) was subjected to a second dry fractionation step and the liquid phase of the second fractionation (00) was subjected to a third fractionation. OOS would then be the solid fraction of that third fractionation.
- Dry fractionation is for instance used to produce butter having superior spreading properties and the production of milk fat fractions for use in bakery applications. It has also been proposed to use a solid fraction of a dry fractionation process in the production of chocolate products, for instance to replace cocoa butter or to change the texture of chocolate but so far literature shows that this has not yet been successful.
- Supercritical fluid fractionation also known as supercritical fluid extraction of liquids
- has been proposed as an alternative to dry fractionation see also the above identified review by Hamm and paper by Arul et al. With this process a raffinate and a distillate is obtained.
- Supercritical fluid fractionation is thought to fractionate fats primarily on the basis of molecular weight.
- EP 74145 Al is an example of a patent application relating to a process wherein supercritical fluid fractionation is used to produce a mixture of triglycerides having butter-like properties.
- the ratio is an example of a patent application relating to a process wherein supercritical fluid fractionation is used to produce a mixture of triglycerides having butter-like properties.
- saturated/unsaturated acyl groups in the fractions can also be altered in a different way than this ratio is altered in dry fractionation.
- fat compositions at least majorly based on milk fat, having specific properties, such as a nutritional value, specific structural properties, specific flavour/aroma properties and the like, as desired for a particular application.
- alternative fat compositions based at least majorly on milk fat.
- fat compositions that more closely resemble mother milk than conventional milk fat fractions. Such compositions are particularly interesting for formulating infant formulas and toddler food products.
- alternative flavouring/aroma compositions based on milk fat.
- alternative fat compositions that are regarded as having a highly nutritional value (e.g. high content of mono- or polyunsaturated fatty acids), yet have another property that is generally thought to be associated with fat components considered less healthy, such as high melting point.
- the invention relates to a process for preparing a fat fractionate, comprising
- the invention relates to a process for preparing a fat fractionate, comprising
- a starting material selected from the group consisting of milk fats and fat mixtures of milk fat and at least one other fat, which fat mixtures are composed of more than 50 wt. % milk fat, preferably at least 90 wt. % milk fat - said starting material preferably being anhydrous -by a supercritical fluid fractionation;
- the invention further relates to a fat fraction obtainable as a fat fractionate by a process according to the invention.
- the invention further relates to a method for making a food product, comprising combining a fat fractionate prepared by a process according to the invention or a fat fraction according to the invention with one or more further (usual) food ingredients for making said food product.
- a process according to the invention is suitable to obtain fat fractions that are different from the starting material and from the intermediate fat fraction in one or more of the following aspects:
- SAFA saturated fatty acids
- MUFA monounsaturated fatty acids
- PUFA polyunsaturated fatty acids
- n3-polyunsaturated fatty acids concentration of n3- polyunsaturated fatty acids
- concentration of n3- polyunsaturated fatty acids concentration of one or more fat-soluble vitamins, such as a fat-soluble vitamin selected from the group of vitamin A, vitamin E, vitamin Kl and vitamin K2; concentration of cholesterol; concentration of one or more specific or total lactones; concentration of one or more specific or total ketones; concentration of one or more specific or total aldehydes; concentration of total short-chain fatty acids (C4-C6, abbreviated as SCFA); concentration of total medium-chain fatty acids (C8-C12, abbreviated as MCFA); concentration of total long-chain fatty acids (C14 or higher, abbreviated as LCFA); concentration of total cis-fatty acids; concentration of
- the fat fractions are different in two or more, more preferably three or more, four or more, five or more, six or more of said aspects.
- the fat fractions are different in twelve or less, in particular ten or less, more in particular eight or less of said aspects.
- milk fat as (the major part of) the starting material, compared to a e.g. a plant fat like palm oil, may be a cause of a synergy achievable in accordance with the invention.
- This complex nature is e.g. reflected in the generally bimodal carbon number distribution of milk fat.
- the synergistic difference is defined as an enrichment or depletion in one or more of said aspects compared to the starting material, wherein
- CDF+SC/ Cstart > Cstart+SC / Cstart ⁇ 1 and synergistically depleted is defined as
- CDF+SC is one of said concentrations in or the carbon number of the fat fractionate obtained by dry fractionation plus the supercritical fluid fractionation of the starting material
- Cstart is one of said concentrations in or the carbon number of the starting material, such as AMF.
- Cstart+sc is one of said concentrations in or the carbon number of a fat fraction obtained by only super critical fluid fractionation of the starting material
- the fat fractionate is enriched in a component or carbon number, usually CDF+SC / Cstart ⁇ 10, in particular CDF+SC / Cstart ⁇ 5, more in particular CDF+SC / Cstan ⁇ 3.5, more in particular CDF+SC /Cstart is about 2.5 or less.
- the fat fractionate is synergistically depleted CDF+SC / Cstart ⁇ Cstan+sc / Cstan ⁇ 0.9, more preferably CDF+SC / Cstart ⁇
- Cstart+sc / Cstart ⁇ 0.8 in particular CDF+SC / Cst rt ⁇ Cstan+sc /Cstan ⁇ 0.65. in an Cstan+sc / Cstan ⁇ 0.9.
- the fat fractionate is depleted in a component or carbon number, usually Cstan+sc / Cstan >0.01, in particular Cstan+sc / Cstan >0.1, more in particular Cstan+sc / Cstan >0.2, more in particular
- Cstart+SC /Cstart IS about 0.3 ⁇ ⁇ .
- substantially(ly) or “essential(ly)” is generally used herein to indicate that it has the general character or function of that which is specified. When referring to a quantifiable feature, these terms are in particular used to indicate that it is for at least 75 %, more in particular at least 90 %, even more in particular at least 95 % of the maximum that feature.
- a product is usually considered essentially free of a substance, in particular water, if the content of the substance is 0- 0.5 wt.%, in particular 0 - 0.2 wt.%, more in particular 0 - 0.1 wt.%, based on total weight of the product in which it is present.
- certain substances such as certain aromas or
- the presence in the starting material may be well below 0.5 wt. %, 0.2 wt.% or 0.1 wt. % and still have a significant effect on a property of the product.
- the term "about” in relation to a value generally includes a range around that value as will be understood by the skilled person. In particular, the range is from at least 15 % below to at least 15 % above the value, more in particular from 10 % below to 10 % above the value, more specifically from 5 % below to 5 % above the value. As used herein, percentages are usually weight percentages unless specified otherwise. Percentages are usually based on total weight, unless specified otherwise.
- fatty acids these in particular include the fatty acid residues (acyl groups) of triglycerides.
- the carbon number is determinably by gas chromatography with flame ionization detection (GC-FID), wherein a sample of a substance to be analysed is dissolved in chloroform and injected in the GC. Identification of the carbon numbers and correction factor for the FID response can be done using BCR-632-A sample 160 from Sigma-Aldrich.
- GC-FID flame ionization detection
- the starting material is usually essentially water-free.
- the starting material is usually milk fat, in particular milk fat that is essentially free of water (anhydrous milk fat, abbreviated as 'AMF').
- AMF can be made in a manner generally known in the art, e.g. using phase inversion and drying.
- AMF is also commercially available, e.g. from Friesland Campina (Amersfoort, the
- the milk fat is bovine milk fat, preferably cow milk fat.
- Buffalo milk fat is another particularly useful starting material.
- the milk fat may in particular be milk fat from milk of another hoofed ungulate, such as sheep milk fat, goat milk fat or camel milk fat. Of these, goat milk fat is preferred. It is also possible to use a mixture of milk fats from milk from different species of mammals.
- a minor amount of one or more other fats, in particular one or more fats from a plant or from aquatic organisms (e.g. fish oil, oil from algae).
- This can be useful, e.g., to provide a starting material with a high mono- or polyunsaturated fatty acid content, e.g. eicosapentaenoic acid (EPA), docosahexanoic acid (DHA) or arachidonic acid (ARA) content .
- EPA eicosapentaenoic acid
- DHA docosahexanoic acid
- ARA arachidonic acid
- the total content of fat other than milk fat in the starting material usually is 0- 20 wt. %,in particular 1-10 wt.%, more in particular 1-5 wt. %, more in particular 1-2 wt. % . Particularly good results have been achieved with a starting material that consists of milk fat, such as AMF.
- a desirable fat fractionate for a specific purpose can be obtained in accordance with the invention by a specific combination of two or more subsequent fractionations, at least one being a dry fractionation and at least one being a supercritical fluid fractionation.
- the dry fractionation conditions and the supercritical fluid fractionation conditions can be based on common general knowledge, the literature cited in the present disclosure, and the contents of the present disclosure, optionally in combination with a limited amount of routine testing.
- Milk fat fractions obtained by dry fractionation can also be provided by a supplier, from which these are available, e.g. FrieslandCampina (Amersfoort, the Netherlands).
- the dry fractionation is usually operated under batch conditions.
- the dry fractionation conditions can generally be based on known conditions, e.g. on the basis of the references mentioned above or the literature cited therein. E.g. The Lipid Handbook, G.D.Gunstone, CRC Pressm, 3 rd Edition, Chapters 4.4.2.4 and 4.4.3, Figure 4.20 and Table 4.17 are indicative of common general knowledge.
- Figure 1 of the present disclosure illustrates (using AMF from cow milk as an example) how a multiple fractionation results in different fractions, how these fractions are generally named, and how the melting temperatures of the fractions usually relate to each other. It should be noted that the quantitative values are indicative only and may vary, in particular dependent on the composition of the starting material.
- solvent/feed ratio outlet temperature, pressure, weight to weight ratio distillate to raffinate play a role.
- supercritical carbon dioxide is particularly suitable, but other known supercritical fluids can be used as an alternative or mixed with carbon dioxide, e.g. one or more supercritical fluids selected from the group of supercritical dinitrogen oxide, supercritical ammonia, supercritical hydrocarbons, supercritical alcohols, halogenated hydrocarbons.
- supercritical points for such fluids are known, e.g. from EP 744922 Bl.
- the supercritical conditions can generally be based on known conditions, e.g. on the basis of the references mentioned above or the literature cited therein.
- the supercritical fractionation can be carried out using equipment that is known per se. It can be a continuous fractionation or a batch fractionation.
- the temperature of the supercritical medium during fraction may be chosen within a wide range.
- the temperature is minimally the temperature corresponding to the critical point of the supercritical medium.
- the temperature is preferably at least 5°C above the critical point, more preferably at least 10°C above the critical point, most preferably at a temperature of at least 15°C above the critical point.
- the temperature is preferably maximally 100°C, more preferably maximally 80°C, more in particular maximally 70°C.
- the temperature is usually chosen such that the fat fraction or starting material subjected to supercritical fractionation is fluid, i.e. above the upper end of the melting range. In particular good results have been achieved with supercritical carbon dioxide at a temperature above the critical point in the range of 45-65 °C.
- the pressure of the supercritical medium may be chosen within a wide range.
- the pressure is minimally the pressure corresponding to the critical point of the supercritical medium.
- the pressure is preferably at least 5 bar above the critical point, more preferably at least 10 bar above the critical point.
- the pressure is usually up to 500 bar above the critical point, in particular 200 bar above the critical point, preferably up to 150 bar above the critical point, in particular up to 100 bar above the critical point.
- the pressure usually is in the range of 100-250 bar, preferably in the range of 105-200 bar. In particular, good results have been achieved with supercritical carbon dioxide at a pressure above the critical point in the range of 110-140 bar.
- the solvent/feed ratio can be chosen at a suitable value within a normal operating range for the equipment is used.
- the ratio is generally chosen high enough to dissolve all of the feed in the supercritical fluid and can be determined empirically. At higher operating pressure, generally a lower solvent/feed ratio is required to dissolve all of the feed.
- the ratio distillate to raffinate to be a particularly important parameter, to achieve specific, in particular synergistic effects on enrichment or depletion of one or more components of interest.
- the weight to weight ratio distillate to raffinate based on the total weight of the fat fraction(ate) in the distillate and in the raffinate, in the supercritical fluid fractionation is in the range of 5:95 to 90:10 , preferably in the range of 10:90 to 70:30, in particular in the range of 15:85 to 50:50.
- a high unsaturated fatty acid content is generally regarded as providing increased nutritional value and tends to have a lowering effect on melting temperature or range.
- Lactones, ketones and aldehydes generally contribute to a characteristic flavour/aroma.
- a fluid fraction provided by dry fractionation is used as an intermediate fat fraction from the starting material (if dry fractionation precedes supercritical fluid fractionation), or the fat fractionate is obtained as a fluid fraction of the dry fractionation (if dry fractionation follows supercritical fluid fractionation).
- the dry fractionation is a multi-step fractionation comprising two or more fractionation steps, wherein the intermediate fat fraction is a solid or fluid fraction obtained after subjecting a fluid fraction of the starting material obtained in a first dry fractionation step is subjected to at least one further dry fractionation step.
- the fat fractionate is a solid or fluid fraction obtained after subjecting a fluid fraction of an intermediate fat fraction (obtained by supercritical fluid fractionation) which fluid fraction is obtained in a first dry fractionation step to at least one further dry fractionation step.
- the invention has been found particularly advantageous with respect to fat fractions obtained as a distillate or raffinate, more in particular as a raffinate of the supercritical fluid fractionation in a process according to the invention.
- a fat fractionate obtained in accordance with the invention may be used as such or be further processed. E.g. it may be subjected to a further fractionation step (dry fractionation, supercritical fractionation or other) or to an
- a fraction obtained in a process according to the invention that is not to be used for further application e.g. for used in the making of a food product, may be subjected to a further process to recover useful components from the fraction. E.g. it may be recycled into a process of the invention.
- the prepared fat fraction is obtained from the 0 fraction (the fluid fraction of the first dry fractionation step) of the dry fractionation, which 0 fraction has been subjected to supercritical fluid fractionation or may have been subjected to a further dry fractionation step to yield the intermediate fraction (e.g. OS, 00, OSO, OSS, OOO, OSOO, OOOO, OSSO) that has been subjected to supercritical fluid fractionation.
- the intermediate fraction e.g. OS, 00, OSO, OSS, OOO, OSOO, OOOO, OSSO
- fractionation e.g. SO, SS
- SO sulfur dioxide
- SS supercritical fluid fractionation
- the term 'distillate' is used for the distillate of the supercritical fluid fractionation
- the term raffinate is used for the raffinate of the supercritical fluid fractionation
- lower melting fraction means olein fractions having a lower melting temperature than the starting material, in particular AMF (typically including 0, 00, 000, 0000 etc.)
- middle melting fraction means stearin fractions having a lower melting temperature than the starting material, in particular AMF (typically including OS, OOS, OOOS high melting fractions means a higher melting temperature than the starting material, in particular AMF
- soft fraction means the olein fraction of a dry fractionation
- hard fraction means the stearin fraction of a dry fractionation
- a distillate of a lower melting fraction is in particular useful as milk fat product with high amounts of naturally occurring bioactive components important for growth and development, such as fat soluble vitamins, vitamin precursors, cholesterol, etc..
- a distillate of a lower melting fraction or intermediate melting fraction is in particular useful as fat product containing high concentrations of short chain fatty acids, such as butyric acid, and/or medium chain fatty acids with immunogenic potential.
- a fat fractionate with enhanced medium chain fatty acids for energy metabolism can be prepared as a distillate of a hard fraction obtained in the dry fractionation.
- High melting fractions are particularly useful for supercritical fluid fractionation to obtain a fat fractionate that is depleted in palmitic acid, without comprising the functionality thereof.
- Supercritical fat fractions obtained from hard intermediate fat fractions are particularly useful in the preparation of chocolate or chocolate fantasy products which are more resistant to blooming caused by large temperature fluctuations.
- Distillates of soft fractions are for instance useful if starting material contains a relatively high trans-fatty acid and a reduction of trans-fatty acid content is desired.
- a distillate obtained by supercritical fluid fractionation of a middle melting fraction is usually enriched in flavour components, in particular if a dry fractionation fraction is used that is obtained as the liquid fraction in the final dry fractionation step ⁇ e.g. O, OO , OOO, or OOOO).
- a relatively low weight to weight ratio of distillate to raffinate is preferred for preparing a fat fractionate enriched in aroma components, such as a ratio of 30:70 or less, in particular about 15:80 to 20:80.
- Such fractionate is particularly useful to impart a butter- like or cream like flavour or aroma to a product or for use as a flavour carrier.
- a raffinate in particular a raffinate obtained by supercritical fluid fractionation of an intermediate fat fraction obtained by dry fractionation selected from 0, 00, OOO and OOOO, is suitable to provide a fat fractionate more closely resembling the fatty acid composition of human milk. Accordingly, such fractionate is particularly useful for the preparation of an infant formulation or toddler food.
- a distillate obtained with a process wherein the supercritical fluid fractionation is operated at a relatively low weight to weight ratio distillate to raffinate, such as of about 50:50 or less, is preferred.
- a raffinate enriched in long chain saturated fatty acid preferably use is made of an intermediate fat fraction obtained by dry fractionation selected from OS and OOO.
- a distillate of a solid intermediate fraction obtained by dry fractionation is useful (especially S), in particular if the ratio distillate to raffinate is relatively low, such as about 50:50 or less.
- a supercritical fluid fractionation For enrichment in vitamin A use may be made of a supercritical fluid fractionation with a relatively high ratio distillate to raffinate, such as a ratio of about 50:50 or more.
- a relatively high ratio distillate to raffinate such as a ratio of about 50:50 or more.
- supercritical fluid fractionation of the OOO fraction of dry fractionation has been found particularly suitable (with the raffinate as the fat fractionate that is
- the invention further relates to the preparation of food products using a fat fractionate (obtainable) in accordance with the invention.
- the food product can generally be prepared in a manner known per se, using known ingredients other than the fat fractionate in known amounts.
- the fat fractionate will usually replace partly or fully a conventional fat source. E.g. in case chocolate product or chocolate imitation product is prepared, the fat fractionate will usually replace cacao butter or a part thereof.
- the food product is a chocolate product or a chocolate-imitation product.
- the food product is an infant formulation.
- the food product is a medical food product, in particular a clinical nutrition product (i.e. a food product for use in enhancing, maintaining or restoring health and/or prevent a disease, prescribed by a health care professional like a physician, nurse, or dietician, and destined for and supplied to persons in need thereof).
- the medical food product may be an infant formulation for infants in need of a special nutrition, e.g. for infants suffering from an allergy or metabolic disease.
- the obtained product is used to manufacture a flavour product or used directly for inclusion in a flavour product.
- Example 1 The invention will now be illustrated by the following examples.
- Example 1 The invention will now be illustrated by the following examples.
- Example 1 The invention will now be illustrated by the following examples.
- AMF from cow milk was subjected to dry fractionation in a single step fractionation to obtain an 0 and an S fraction, and to multi-step fractionation to obtain various soft and hard fractions, for further fractionation by supercritical fluid fractionation.
- the dry fractionation process parameters were based on common general knowledge to obtain the fractions.
- the supercritical C02 extraction took place on a pilot facility with a 4.5 m high and 10 1 capacity column filled with 2 mm stainless steel Raschig rings. The inner diameter of the column was 54mm. In all tests the raw material was fed from the middle of the column (2.25 m from the bottom). First optimal conditions were determined using AMF and dry fractionation fractions as a feed material using batch extraction experiments. Also conditions were determined to achieve different distillate / raffinate ratios.
- the OOOO fraction and the AMF were subjected to continuous supercritical fractionation; conditions were based on the findings of Example 1.
- a distillate and a raffinate were obtained under the same conditions. In this case comparable yields of 15% distillate versus 85% of raffinate were obtained for both the AMF and the OOOO fraction.
- the distillates were analysed by the same FA analysis. In the following table the results are shown.
- synergy factor for AMF needs to be >1 and the synergy factor for OOOO needs to be larger than for AMF which is both true. So in this case there is synergistic enrichment of butyric acid in these fractions.
- AMF and an OOOO fraction were prepared as raw materials and analysed on trans fatty acid content by means of fatty acid analysis, as described in Example 2.
- the OOOO fraction and the AMF were subjected to continuous supercritical fractionation; conditions were based on the findings of Example 1.
- a distillate and a raffinate were obtained under comparable conditions. In this case comparable yields of 15% distillate versus 85% of raffinate were obtained for both the AMF and the OOOO fraction.
- the distillates were analysed by the same FA analysis. In the following table the results are shown:
- synergy factor for AMF needs to be >1 and the synergy factor for OOO needs to be larger than for AMF which is both true. So in this case there is synergistic enrichment of medium chain fatty acids in these fractions.
- AMF from cow milk
- OS from cow milk
- OOO fatty acid
- the fractions were subjected to continuous supercritical fractionation; conditions were based on the findings of Example 1.
- a distillate and a raffinate were obtained under comparable conditions. In this case comparable yields of 50% distillate versus 50% of raffinate were obtained for both the AMF and the OOO fraction.
- the raffinates were analysed by the same FA analysis as in Example 2. In the following table the results are shown:
- synergy factor for AMF needs to be >1 and the synergy factor for OOO needs to be larger than for AMF which is both true. So in this case there is synergistic enrichment of medium chain fatty acids in these fractions.
- flavour molecules can be concentrated synergistically by means of supercritical C02 fractionation.
- AMF from cow milk
- an OOOO fraction were prepared as raw materials. Equal amounts of these products were put in aluminium coated glass jars at room temperature. These samples were tested blindly by an experienced group of testers familiar with butter and butter products against a standard which was AMF and asked to grade the product on a 5 point scale, 1 clearly less intense, 2: slightly less intense, 3 equally intense, 4: slightly more intense and 5: clearly more intense.
- the ranking points were collected per person added per sample and summarised in the following table.
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16204481 | 2016-12-15 | ||
PCT/EP2017/083137 WO2018109203A2 (en) | 2016-12-15 | 2017-12-15 | Two-dimensional fractionation of milk fat |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3555254A2 true EP3555254A2 (en) | 2019-10-23 |
Family
ID=57754962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17825810.9A Pending EP3555254A2 (en) | 2016-12-15 | 2017-12-15 | Two-dimensional fractionation of milk fat |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3555254A2 (en) |
CN (1) | CN110072984A (en) |
WO (1) | WO2018109203A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113030290B (en) * | 2021-01-12 | 2022-11-08 | 广州金至检测技术有限公司 | Detection method and detection kit for vitamin K2 in milk powder |
WO2023232962A1 (en) * | 2022-06-02 | 2023-12-07 | Frieslandcampina Nederland B.V. | Fat blend suitable for infant nutrition |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4504503A (en) | 1981-09-09 | 1985-03-12 | Lever Brothers Company | Fractionation of butterfat using a liquefied gas or a gas in the supercritical state |
US5395531A (en) * | 1992-09-28 | 1995-03-07 | Pall Corporation | Method for fractionating a fat composition |
CA2166421C (en) * | 1993-07-02 | 1999-07-06 | Arnoldus Van Der Heijden | Flavouring composition |
ATE164303T1 (en) | 1994-02-18 | 1998-04-15 | Gaya Ltd | SURGICAL DEVICE |
JP3588902B2 (en) * | 1996-03-28 | 2004-11-17 | 不二製油株式会社 | Dry separation of fats and oils |
NZ503398A (en) * | 1997-08-18 | 2002-06-28 | Univ South Dakota | Dairy products with enhanced conjugated linoleic acid content derived from milk of ruminants fed with fish oil |
CN1451729A (en) * | 2003-03-25 | 2003-10-29 | 江南大学 | Method for extracting yolk oil by enzyme hydrolysis-solvent extraction |
CN102504962B (en) * | 2011-11-10 | 2014-04-02 | 中国科学院合肥物质科学研究院 | Process for preparing polyunsaturated fatty acids (PUFAs) from microbial origin |
US9980506B2 (en) * | 2013-03-11 | 2018-05-29 | Mead Johnson Nutrition Co. | Nutritional compositions containing structured fat globules and uses thereof |
CN104212636B (en) * | 2014-09-02 | 2016-06-22 | 天津大学 | A kind of method based on melting layer crystallization technique separation of cream fat |
-
2017
- 2017-12-15 WO PCT/EP2017/083137 patent/WO2018109203A2/en unknown
- 2017-12-15 EP EP17825810.9A patent/EP3555254A2/en active Pending
- 2017-12-15 CN CN201780077429.2A patent/CN110072984A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2018109203A2 (en) | 2018-06-21 |
WO2018109203A3 (en) | 2018-08-09 |
CN110072984A (en) | 2019-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5088347B2 (en) | Texture improving oil and fat composition | |
JP5241284B2 (en) | Oil composition for sand cream | |
JP5976968B1 (en) | Oil and fat composition and method for producing the same | |
JPS5891799A (en) | Manufacture of mixed triglyceride | |
JP2021011576A (en) | Preparation and composition of medium chain triglycerides containing substantial amount of lauric acid | |
JP6225278B2 (en) | Plastic oil composition | |
JP6854679B2 (en) | Freezing confectionery mix and frozen confectionery using it | |
JP2021520186A (en) | New high stearin oil seed stearin fat and its preparation | |
Choudhary et al. | Palm (Elaeis guineensis jacq.) oil | |
BR112018013001B1 (en) | FAT COMPOSITION FOR UNTEMPERED CHOCOLATE AND LOW TRANS FAT CHOCOLATE | |
JP6578095B2 (en) | Tempura frying oil and method for producing the tempura frying oil | |
EP3555254A2 (en) | Two-dimensional fractionation of milk fat | |
JPH05507107A (en) | Countercurrent liquid/liquid extraction for fractionation of complex mixtures containing medium and long chain fatty acid triglycerides | |
Goli et al. | Enzymatic interesterification of structured lipids containing conjugated linoleic acid with palm stearin for possible margarine production | |
JP6851867B2 (en) | Freezing confectionery mix and frozen confectionery using it | |
JP6786160B2 (en) | Liquid whitener | |
Mota et al. | Natural crystallisation of tucuma (Astrocaryum vulgare Mart.) pulp olein | |
WO2014038670A1 (en) | Foamable oil-in-water emulsified oil or fat composition | |
JP5729731B2 (en) | Oil composition for sand cream | |
CN105028678A (en) | Flavored intelligence-reinforcing artificial cream | |
RU2580143C1 (en) | Baking margarine | |
Sari et al. | Glycerolysis-interesterification of chicken-palm stearin blend: effect of solvent and chicken stearin to palm stearin ratio | |
JP6893733B2 (en) | Frozen confectionery mix and frozen confectionery using it | |
JP7376226B2 (en) | Oil and fat composition for baked confectionery | |
Kar et al. | Isopropanol fractionation of coconut oil into its olein and stearin fractions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20190517 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |